Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-12-02T21:49:15.787Z Has data issue: false hasContentIssue false
  • English
  • Français

Ethnicity and Other Possible Risk Factors for Candidemia at 3 Tertiary Care University Hospitals in Hawaii

Published online by Cambridge University Press:  21 June 2016

Shigeki Fujitani ,
M. Ricardo-Dukelow ,
Toru Kamiya ,
Loretta Sullivan  and
Lewis Low
Shigeki Fujitani*
Affiliation:
Department of Medicine, University of Hawaii, Honolulu, Hawaii
M. Ricardo-Dukelow
Affiliation:
Department of Medicine, University of Hawaii, Honolulu, Hawaii
Toru Kamiya
Affiliation:
Department of Medicine, University of Hawaii, Honolulu, Hawaii
Loretta Sullivan
Affiliation:
Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, California
Lewis Low
Affiliation:
Department of Medicine, University of Hawaii, Honolulu, Hawaii Department of Medicine, Legacy Health System, Portland, Oregon
*
VA Greater Los Angeles Healthcare System, Infectious Diseases Section 111F, 11301 Wilshire Boulevard, Los Angeles, CA 90073 ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

A total of 108 cases of candidemia detected in 3 tertiary care university hospitals in Hawaii between January 2001 and December 2002 were retrospectively reviewed. Candida albicans, Candida glabrata, and Candida tropicalis accounted for 28% of the cases. Mortality among Filipino patients was significantly higher than that among other ethnic groups (71% vs 48%; P<.05).

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 27 , Issue 11 , November 2006 , pp. 1261 - 1263
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Health HSDo. Hawaii Health Survey 2003. Available at: http://www.hawaii.gov/health/statistics/hhs/hhs_03/hhs03t11.pdf. Accessed 20 October 2006.Google Scholar
2. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986–April 1996, issued May 1996: a report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 1996; 24:380–388.CrossRefGoogle Scholar
3. Diekema, DJ, Messer, SA, Brueggemann, AB, et al. Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol 2002; 40:1298–1302.Google Scholar
4. Kao, AS, Brandt, ME, Pruitt, WR, et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 1999; 29:1164–1170.Google Scholar
5. Pappas, PG, Rex, JH, Lee, J, et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 2003; 37:634–643.Google Scholar
6. Pfaller, MA, Jones, RN, Doern, GV, et al. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob Agents Chemother 2000; 44:747–751.Google Scholar
7. Pfaller, MA, Jones, RN, Messer, SA, Edmond, MB, Wenzel, RP. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program, SCOPE Participant Group, Surveillance and Control of Pathogens of Epidemiologic. Diagn Microbiol Infect Dis 1998; 30:121–129.Google Scholar
8. Rangel-Frausto, MS, Wiblin, T, Blumberg, HM, et al. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999; 29:253–258.CrossRefGoogle ScholarPubMed
9. Uzun, O, Ascioglu, S, Anaissie, EJ, Rex, JH. Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia. Clin Infect Dis 2001; 32:1713–1717.Google Scholar
10. Wingard, JR, Merz, WG, Saral, R. Candida tropicalis: a major pathogen in immunocompromised patients. Ann Intern Med 1979; 91:539–543.Google Scholar
11. Meckstroth, KL, Reiss, E, Keller, JW, Kaufman, L. Detection of antibodies and antigenemia in leukemic patients with candidiasis by enzyme-linked immunosorbent assay. J Infect Dis 1981; 144:24–32.Google Scholar
12. Wingard, JR, Vaughan, WP, Braine, HG, Merz, WG, Saral, R. Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole. Am J Med 1987; 83:1103–1110.Google Scholar
13. Komshian, SV, Uwaydah, AK, Sobel, JD, Crane, LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989; 11:379–390.CrossRefGoogle ScholarPubMed
14. Nucci, M, Silveira, MI, Spector, N, et al. Fungemia in cancer patients in Brazil: predominance of non-Albicans species. Mycopathologia 1998; 141:65–68.Google Scholar
15. Mathews, MS, Samuel, PR, Suresh, M. Emergence of Candida as the major cause of fungaemia in India. Mycoses 2001; 44:278–280.CrossRefGoogle ScholarPubMed
16. Leung, AY, Chim, CS, Ho, PL, et al. Candida fungaemia in adult patients with haematological malignancies: clinical features and risk factors. J Hosp Infect 2002; 50:316–319.Google Scholar
17. Shin, JH, Kim, MN, Shin, DH, et al. Genetic relatedness among Candida tropicalis isolates from sporadic cases of fungemia in two university hospitals in Korea. Infect Control Hosp Epidemiol 2004; 25:634–640.Google Scholar
18. Crum, NF, Lederman, ER, Stafford, CM, Parrish, JS, Wallace, MR. Coccidioidomycosis: a descriptive survey of a reemerging disease: clinical characteristics and current controversies. Medicine (Baltimore) 2004; 83:149–175.Google Scholar
19. Pappas, PG, Rex, JH, Sobel, JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004; 38:161–189.CrossRefGoogle ScholarPubMed